These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35719107)

  • 21. Clinical Characteristics of Patients Who Contracted the SARS-CoV-2 Omicron Variant from an Outbreak in a Single Hospital.
    Sohn YJ; Shin PJ; Oh WS; Kim E; Kim Y; Kim YK
    Yonsei Med J; 2022 Aug; 63(8):790-793. PubMed ID: 35914762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia.
    Parry H; McIlroy G; Bruton R; Damery S; Tyson G; Logan N; Davis C; Willett B; Zuo J; Ali M; Kaur M; Stephens C; Brant D; Otter A; McSkeane T; Rolfe H; Faustini S; Richter A; Lee S; Wandroo F; Shafeek S; Pratt G; Paneesha S; Moss P
    J Hematol Oncol; 2022 Jan; 15(1):3. PubMed ID: 35000597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia.
    Morawska M
    Eur J Haematol; 2022 Feb; 108(2):91-98. PubMed ID: 34717004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report.
    Cuneo A; Scarfò L; Reda G; Varettoni M; Quaglia FM; Marchetti M; De Paoli L; Re F; Pietrasanta D; Rigolin GM; Orsucci L; Ibatici A; Gattei V; Mauro FR; Trentin L; Laurenti L; Marasca R; Foà R
    Blood; 2020 Aug; 136(6):763-766. PubMed ID: 32559271
    [No Abstract]   [Full Text] [Related]  

  • 25. Superspreading potential of COVID-19 outbreak seeded by Omicron variants of SARS-CoV-2 in Hong Kong.
    Guo Z; Zhao S; Lee SS; Mok CKP; Wong NS; Wang J; Jia KM; Wang MH; Yam CHK; Chow TY; Chong KC; Yeoh EK
    J Travel Med; 2022 Sep; 29(6):. PubMed ID: 35435992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid decrease of nasopharyngeal SARS-CoV-2 antigen in an outbreak of the Omicron strain.
    Nagasawa M; Kato T; Yamaguchi Y; Sugita Y; Kajiwara H
    J Med Virol; 2023 Jan; 95(1):e28179. PubMed ID: 36175007
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
    Cuneo A; Rigolin GM; Coscia M; Quaresmini G; Scarfò L; Mauro FR; Motta M; Quaglia FM; Trentin L; Ferrario A; Laurenti L; Reda G; Ferrari A; Pietrasanta D; Sportoletti P; Re F; De Paoli L; Foglietta M; Giordano A; Marchetti M; Farina L; Del Poeta G; Varettoni M; Chiurazzi F; Marasca R; Malerba L; Ibatici A; Tisi MC; Stefoni V; Leone M; Baratè C; Olivieri J; Murru R; Gentile M; Sanna A; Gozzetti A; Gattei V; Gottardi D; Derenzini E; Levato L; Orsucci L; Penna G; Chiarenza A; Foà R
    Hematol Oncol; 2021 Oct; 39(4):570-574. PubMed ID: 34258787
    [No Abstract]   [Full Text] [Related]  

  • 28. A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland.
    Lorthe E; Bellon M; Berthelot J; Michielin G; L'Huillier AG; Posfay-Barbe KM; Azman AS; Guessous I; Maerkl SJ; Eckerle I; Stringhini S;
    Lancet Infect Dis; 2022 Jun; 22(6):767-768. PubMed ID: 35429994
    [No Abstract]   [Full Text] [Related]  

  • 29. SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia.
    Mellinghoff SC; Robrecht S; Mayer L; Weskamm LM; Dahlke C; Gruell H; Vanshylla K; Schlösser HA; Thelen M; Fink AM; Fischer K; Klein F; Addo MM; Eichhorst B; Hallek M; Langerbeins P
    Leukemia; 2022 Feb; 36(2):562-565. PubMed ID: 34937858
    [No Abstract]   [Full Text] [Related]  

  • 30. Impaired humoral immune response in a COVID‑19 patient with chronic lymphocytic leukemia complicated by spontaneous pneumomediastinum and hemophagocytic lymphohistiocytosis syndrome.
    Stępień A; Nowak W; Stachura T; Marcinek P; Soja J; Sładek K
    Pol Arch Intern Med; 2021 Dec; 131(12):. PubMed ID: 34619954
    [No Abstract]   [Full Text] [Related]  

  • 31. Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia.
    Favresse J; Eucher C; Elsen M; Graux C; Goebels P; Laffineur K; Nicolas JB; Dogné JM; Douxfils J
    Br J Haematol; 2020 Aug; 190(4):e187-e189. PubMed ID: 32557555
    [No Abstract]   [Full Text] [Related]  

  • 32. Heterologous SARS-CoV-2 vaccinations in patients with B-cell lymphoid malignancies.
    Ujjani C; Greninger AL; Shadman M; Hill JA; Lynch RC; Warren EH; Gopal AK
    Am J Hematol; 2022 Feb; 97(2):E67-E69. PubMed ID: 34807468
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic lymphocytic leukemia/small lymphocytic lymphoma presenting as septic arthritis of the shoulder.
    Donovan A; Schweitzer ME; Garcia RA; Nomikos G
    Skeletal Radiol; 2008 Nov; 37(11):1035-9. PubMed ID: 18521594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EXPRESSION OF IMMUNOGLOBULIN SEQUENCES HOMOLOGOUS TO ANTI-SARS-CoV-2 ANTIBODIES AND HIV IN CHRONIC LYMPHOCYTIC LEUKEMIA CASES.
    Abramenko I; Bilous N; Chumak A; Martina Z; Dyagil I; Bazyka D
    Exp Oncol; 2022 Nov; 44(3):208-212. PubMed ID: 36325706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Has Omicron Changed the Evolution of the Pandemic?
    Lundberg AL; Lorenzo-Redondo R; Ozer EA; Hawkins CA; Hultquist JF; Welch SB; Prasad PVV; Oehmke JF; Achenbach CJ; Murphy RL; White JI; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jan; 8(1):e35763. PubMed ID: 35072638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of unprovoked venous thromboembolic events in patients with chronic lymphocytic leukemia.
    Katkish LA; Rangaraju S; Rector TS; Gravely AA; Johnson GJ; Klein MA; Gupta P
    Leuk Lymphoma; 2018 Feb; 59(2):509-511. PubMed ID: 28651451
    [No Abstract]   [Full Text] [Related]  

  • 37. Concurrent chronic lymphocytic leukemia and cutaneous T cell lymphoma: a case series.
    Singh L; Boulavsky JL; Duvic M
    Leuk Lymphoma; 2014 Sep; 55(9):2192-5. PubMed ID: 24313830
    [No Abstract]   [Full Text] [Related]  

  • 38. Effectiveness of CoronaVac in children 3-5 years of age during the SARS-CoV-2 Omicron outbreak in Chile.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Acevedo J; Pizarro A; Vergara V; Soto-Marchant M; Gilabert R; Flores JC; Suárez P; Leighton P; Eguiguren P; Ríos JC; Fernandez J; García-Escorza H; Araos R
    Nat Med; 2022 Jul; 28(7):1377-1380. PubMed ID: 35605637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Cases from the First Local Outbreak of the SARS-CoV-2 B.1.1.7 Variant in China May Present More Serious Clinical Features: A Prospective, Comparative Cohort Study.
    Song Y; Ge Z; Cui S; Tian D; Wan G; Zhu S; Wang X; Wang Y; Zhao X; Xiang P; Xu Y; Zhang T; Liu L; Liu G; Wang Y; Tan J; Zhang W; Xu W; Chen Z
    Microbiol Spectr; 2021 Sep; 9(1):e0027321. PubMed ID: 34346755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!
    Rahmani S; Rezaei N
    Acta Biomed; 2022 May; 93(2):e2022097. PubMed ID: 35546004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.